XML 18 R6.htm IDEA: XBRL DOCUMENT v3.21.2
CONDENSED CONSOLIDATED STATEMENT OF STOCKHOLDERS' EQUITY - USD ($)
$ in Millions
Total
Common stock
Additional paid-in capital
Treasury stock at cost
Retained earnings
Accumulated other comprehensive income
Beginning balance at Dec. 31, 2019   $ 2 $ 16,126 $ (31,396) $ 17,754 $ 384
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Common stock issued   0        
Common stock repurchased   0        
Common stock and stock-based awards issued     54      
Tax withholdings related to net share settlements of restricted stock units and awards     (131)      
Stock-based compensation     332      
Common stock repurchased     0 (4,700)    
Other     (8)      
Net income $ 4,822       4,822  
Dividends and dividend equivalents declared         (346)  
Foreign currency translation adjustment           57
Change in unrealized gains (losses) on investments 1         1
Change in unrealized gains (losses) on derivative instruments           (41)
Tax benefit (provision) on above items           10
Ending balance at Sep. 30, 2020 $ 2,920 2 16,373 (36,096) 22,230 411
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Dividends and dividend equivalents declared per share or restricted stock unit (in usd per share) $ 0.48          
Beginning balance at Jun. 30, 2020   2 15,844 (34,946) 21,681 321
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Common stock issued   0        
Common stock repurchased   0        
Common stock and stock-based awards issued     5      
Tax withholdings related to net share settlements of restricted stock units and awards     (48)      
Stock-based compensation     122      
Common stock repurchased     450 (1,150)    
Other     0      
Net income $ 664       664  
Dividends and dividend equivalents declared         (115)  
Foreign currency translation adjustment           121
Change in unrealized gains (losses) on investments 0         0
Change in unrealized gains (losses) on derivative instruments           (41)
Tax benefit (provision) on above items           10
Ending balance at Sep. 30, 2020 $ 2,920 2 16,373 (36,096) 22,230 411
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Dividends and dividend equivalents declared per share or restricted stock unit (in usd per share) $ 0.16          
Beginning balance at Dec. 31, 2020 $ 3,561 2 16,497 (36,515) 22,961 616
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Common stock issued   0        
Common stock repurchased   0        
Common stock and stock-based awards issued     59      
Tax withholdings related to net share settlements of restricted stock units and awards     (186)      
Stock-based compensation     386      
Common stock repurchased (4,042)   0 (4,044)    
Other     (6)      
Net income 11,639       11,639  
Dividends and dividend equivalents declared         (370)  
Foreign currency translation adjustment           (192)
Change in unrealized gains (losses) on investments (4)         (4)
Change in unrealized gains (losses) on derivative instruments           130
Tax benefit (provision) on above items           (28)
Ending balance at Sep. 30, 2021 $ 10,945 2 16,750 (40,559) 34,230 522
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Dividends and dividend equivalents declared per share or restricted stock unit (in usd per share) $ 0.54          
Beginning balance at Jun. 30, 2021   2 16,676 (38,308) 34,086 560
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Common stock issued   0        
Common stock repurchased   0        
Common stock and stock-based awards issued     1      
Tax withholdings related to net share settlements of restricted stock units and awards     (58)      
Stock-based compensation     130      
Common stock repurchased     0 (2,251)    
Other     1      
Net income $ 264       264  
Dividends and dividend equivalents declared         (120)  
Foreign currency translation adjustment           (85)
Change in unrealized gains (losses) on investments 0         0
Change in unrealized gains (losses) on derivative instruments           60
Tax benefit (provision) on above items           (13)
Ending balance at Sep. 30, 2021 $ 10,945 $ 2 $ 16,750 $ (40,559) $ 34,230 $ 522
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Dividends and dividend equivalents declared per share or restricted stock unit (in usd per share) $ 0.18